CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 


Biotechnology & Drugs Industry

Management Effectiveness Information & Trends 
 
Select the Industry: Select the Category: Select the Period:

Biotechnology & Drugs Industry 1 Q 4 Q 3 Q 2 Q 1 Q
  2017 2016 2016 2016 2016
Return On Assets (TTM) 10.37 % 11.87 % 9 % - -
Return On Assets Ranking # 7 # 4 # 8 # 96 # 94
Return On Investment (TTM) 14.05 % 16.26 % 20.5 % - -
Return On Investment Ranking # 28 # 18 # 9 # 95 # 94
Return On Equity (TTM) 25.11 % 28.67 % 28.43 % - -
Return On Equity Ranking # 16 # 17 # 13 # 93 # 96


Roa Comment

Biotechnology & Drugs Industry yielded return on assets in 1 Q 2017 above Industry average at 10.37 %.

ROA decreased compare to previous quarter, due to detoriation of net income.
Within Healthcare sector, Biotechnology & Drugs Industry achieved highest return on assets. Return on assets total ranking has deteriorated compare to previous quarter from 4 to 7.

 
Note, first quarter Numbers include only companies who have reported first quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Return On Assets Statistics
High Average Low
15.5 % 7.83 % -12.15 %
4. quarter 2014   1. quarter 2016

Return On Assets Industry Ranking
Within: No.
Sector # 1
S&P 500 # 7

You need to upgrade your Flash Player


Other ROA
Compare Industry's ROE to Nxrt's or S&P Constituent list of Biotechnology & Drugs Industry
Highest Ranking Return On Assets Lowest Ranking Return On Assets
Return On Assets for NXRT's Competitors Definiton of Return On Assets


Biotechnology & Drugs Industry Return On Investment Statistics


 
You need to upgrade your Flash Player

 
Return On Investment Statistics
High Average Low
20.5 % 9.18 % -17.27 %
3. quarter 2016   1. quarter 2016

Roi Comment
Biotechnology & Drugs Industry achieved return on average invested assets of 14.05 % in 1 Q 2017, above Industry average return on investment.

ROI decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest return on investment. Return on investment total ranking has deteriorated compare to previous quarter from 18 to 28.

Return On Investment Industry Ranking
Within: No.
Sector # 1
S&P 500 # 28
Other ROI
Compare Industry's ROI to Nxrt's or S&P Constituent list of Biotechnology & Drugs Industry
Highest Ranking Return On Investments Lowest Ranking Return On Investments
Return On Investments for NXRT's Competitors Definiton of Return On Investments


Biotechnology & Drugs Industry Return On Equity Statistics


 
Return On Equity Industry Ranking
Within: No.
Sector # 1
S&P 500 # 16

Roe Comment
Biotechnology & Drugs Industry returned in 1 Q 2017 25.11 % on shareholder's equity, above Industry average return on equity.

ROE decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest return on equity. Return on equity total ranking has impoved so far to 16, from total ranking in previous quarter at 17.

Return On Equity Statistics
High Average Low
35.85 % 14.63 % -21.15 %
4. quarter 2014   1. quarter 2016

 
You need to upgrade your Flash Player
Other ROE
Compare Industry's Return On Equity to Nxrt's or S&P Constituent list of Biotechnology & Drugs Industry
Highest Ranking Return On Equity Lowest Ranking Return On Equity
Return On Equity for NXRT's Competitors Definiton of Return On Equity




CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com